Cytomedix, Inc. (AMEX:GTF), today announced that a presentation based on the clinical trial for the AutoloGel(tm) System, received the “Outstanding Oral Abstract Presentation” award at the American Podiatric Medical Association Annual Scientific Meeting that was held August 7 though 10 in Las Vegas, Nev.
